Product Information

ORPHENADRINE ER 100 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.4882 per EA under NDC 43386048024. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Jun 19, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ORPHENADRINE ER 100 MG TABLET

ORPHENADRINE CITRATE
$0.4882per EA

Strength

100 mg/1

NDC

43386048024

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ORPHENADRINE CITRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA040284

FDA Approved

6/19/1998

TE Code

AB

On Market Since

6/19/1998

Pharmacological Classes

Centrally-mediated Muscle Relaxation
Muscle Relaxant

Price Statistics

The NADAC for ORPHENADRINE ER 100 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 31.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4882 per EA
All-time high$0.5364 (Dec 14, 2022)
All-time low$0.2632 (Jan 22, 2020)
52-week high$0.4882
52-week low$0.4309
Median price$0.3898
Average price$0.3886
Largest weekly change+70.2% (Aug 19, 2020)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+1.7%

1M

+7.6%

3M

+6.4%

6M

+6.7%

1Y

+12.3%

3Y

-6.5%

5Y

+72.1%

All

+31.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 31%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ORPHENADRINE ER 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ORPHENADRINE ER 100 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.4882 per EA (NDC 43386048024), effective Nov 18, 2026.

How has the price of ORPHENADRINE ER 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for ORPHENADRINE ER 100 MG TABLET has risen 31.2%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ORPHENADRINE ER 100 MG TABLET?

Since Nov 28, 2013, the NADAC for ORPHENADRINE ER 100 MG TABLET has ranged from a low of $0.2632 (Jan 22, 2020) to a high of $0.5364 (Dec 14, 2022), with a median of $0.3898 per EA.

Are there cheaper alternatives to ORPHENADRINE ER 100 MG TABLET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ORPHENADRINE ER 100 MG TABLET, is $0.3361 per EA — about 31% below ORPHENADRINE ER 100 MG TABLET.

Who manufactures ORPHENADRINE ER 100 MG TABLET?

ORPHENADRINE ER 100 MG TABLET (NDC 43386048024) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.